Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elicio Therapeutics (ELTX) Cash from Investing Activities (2020 - 2025)

Elicio Therapeutics filings provide 4 years of Cash from Investing Activities readings, the most recent being -$45000.0 for Q3 2023.

  • On a quarterly basis, Cash from Investing Activities changed N/A to -$45000.0 in Q3 2023 year-over-year; TTM through Dec 2023 was -$32000.0, a 95.11% increase, with the full-year FY2025 number at -$16000.0, up 80.95% from a year prior.
  • Cash from Investing Activities hit -$45000.0 in Q3 2023 for Elicio Therapeutics, down from $30000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $30000.0 in Q2 2023 to a low of -$559000.0 in Q2 2022.
  • Median Cash from Investing Activities over the past 4 years was -$36000.0 (2021), compared with a mean of -$85307.7.
  • Biggest five-year swings in Cash from Investing Activities: plummeted 6000.0% in 2021 and later surged 105.37% in 2023.
  • Elicio Therapeutics' Cash from Investing Activities stood at -$10000.0 in 2020, then tumbled by 260.0% to -$36000.0 in 2021, then tumbled by 163.89% to -$95000.0 in 2022, then skyrocketed by 52.63% to -$45000.0 in 2023.
  • The last three reported values for Cash from Investing Activities were -$45000.0 (Q3 2023), $30000.0 (Q2 2023), and -$17000.0 (Q1 2023) per Business Quant data.